Video
In this video, Mary M. Bridgeman, PharmD, discusses what makes nail fungus particularly difficult to treat.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
2 Commerce Drive
Cranbury, NJ 08512